HCW Biologics enters exclusive distribution deal for HCW11-006
HCW Biologics entered an exclusive distribution agreement with Akron Biotech to commercialize HCW11-006 as a reagent used to support production of highly functional human CAR-T cells.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.